The EMA has started the evaluation of the application submitted by Moderna to obtain the green light for the use of its anti-Covid vaccine Spikevax for children between the ages of 6 and 11.
Covid, the EMA starts the evaluation of the Moderna vaccine for the 6-11 age group
2021-11-10T10:31:58.552Z
To get the green light to use its anti-Covid vaccine (ANSA) The EMA has started the evaluation of the application submitted by Moderna to obtain the green light for the use of its anti-Covid vaccine Spikevax for children between the ages of 6 and 11.